Contracts › 75N93019C00062
75N93019C00062: B Cell Epitope Discovery and Mechanisms of Antibody Protection
Awarded to Washington University, the by National Institutes of Health (NIH).
$11.7Mobligated
$11.7Mpotential value
14 August 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93019C00062 |
|---|---|
| Awardee | Washington University, the |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541713 Research and Development in Nanotechnology |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MO |
| Offers received | 8 |
| Period of performance | 16 September 2019 to 14 August 2026 |
| Potential end | 14 August 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541713 contracts · All expiring contracts · USASpending record